Welcome to our dedicated page for Univest Financial SEC filings (Ticker: UVSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Univest Financial Corp’s credit-loss tables, net-interest-margin footnotes, and derivative hedging schedules can feel like reading a new language. If you have ever wondered, “Where can I see Univest Financial Corp insider trading Form 4 transactions before markets react?” or struggled to pinpoint dividend details in a 200-page report, this page was built for you.
Our AI instantly converts every Univest Financial Corp quarterly earnings report 10-Q filing, annual report 10-K simplified, and surprise 8-K material events explained into plain-English takeaways. With real-time feeds from EDGAR, you receive Form 4 insider transactions real-time, side-by-side with concise risk-factor highlights. Need the numbers behind rising provision expenses? Select the 10-Q and let our tool deliver a line-item earnings report filing analysis in seconds—no hunting through footnotes. It’s all part of understanding Univest Financial Corp SEC documents with AI.
Beyond raw filings, Stock Titan surfaces insights investors actually use: track commercial-loan growth by region, compare fee income from wealth management year over year, and review Univest Financial Corp executive stock transactions Form 4 around dividend declarations. Drill into the proxy statement executive compensation to see how incentive pay links to return-on-assets, or examine liquidity metrics flagged by regulators. Whether you need SEC filings explained simply or want to monitor capital ratios between calls, our comprehensive coverage keeps you ahead of the next disclosure.
Tender offer completed: Eli Lilly subsidiary Ridgeway Acquisition’s cash-and-CVR offer for Verve Therapeutics (VERV) expired at 12:00 a.m. ET on 24-Jul-2025. The depositary reported 49,882,464 shares—about 55.7 % of outstanding—were validly tendered and not withdrawn, satisfying the minimum tender condition.
Consideration: Tendering shareholders will receive $10.50 in cash per share plus one non-tradable contingent value right (CVR) that may pay up to $3.00 upon a specified milestone.
Next steps: Lilly has accepted the shares for payment and will promptly remit the cash and issue CVRs. A second-step merger is expected on 25-Jul-2025; untendered shares will convert into the same cash-plus-CVR consideration. Following closing, Verve will be delisted from Nasdaq and its registration under the Exchange Act terminated.
A joint press release announcing the results was filed as Exhibit (a)(5)(H).
FAQ
What is the current stock price of Univest Financial (UVSP)?
What is the market cap of Univest Financial (UVSP)?
What are the primary business segments of Univest Financial Corp?
Which customer groups does Univest serve?
How does Univest generate the majority of its revenue?
What differentiates Univest Financial Corp from its competitors?
Where is Univest Financial Corp headquartered?
What types of financial solutions does Univest offer?
How does Univest ensure quality customer service?
What role does community engagement play in Univest's business model?
